Medication Monitor



Generic Name (Trade Name—Company)
Notes
February 12, 2018

Ferumoxytol injection

(Feraheme—Amag Pharmaceuticals)
Product now a treatment option for eligible adult patients with iron deficiency anemia

FDA has expanded the indication for ferumoxytol injection beyond treatment for current chronic kidney disease (CKD) to include all eligible adult patients with iron deficiency anemia (IDA) who have intolerance to oral iron or have had unsatisfactory response to oral iron.

The drug provides 1 g of iron in two doses that can be administered in 15 minutes and as few as 3 days apart.